Religare keeps Buy on ICICI Life, sees 42.6% upside
In short
Religare Broking kept a Buy rating on ICICI Life Insurance and set a target price of ₹650. It says that could mean 42.6% upside from the current level.
This matters to investors because it shows a positive broker view, even though some product areas may be weak in the near term. The source does not state the current share price or how long the slowdown may last.
What the reporting says
Religare Broking reiterated a 'Buy' rating on ICICI Life Insurance and set a target price of ₹650, implying 42.6% upside. The brokerage cited leadership continuity, distribution strategy and operating efficiency as growth drivers, while warning of near-term softness in some product segments. The immediate consequence is a supportive analyst view for the stock, though the source does not provide the latest share price.
Why it matters
Religare Broking reiterated a Buy rating on ICICI Life Insurance with a ₹650 target price, implying 42.6% upside. The publisher summary says the brokerage sees leadership continuity, distribution strategy and operating efficiency as growth drivers, while noting near-term softness in some product segments. The note is relevant to ICICI Life shareholders and insurance-market watchers, but the current stock price is not stated.